← back to search

Anna Gonye

Massachusetts Institute of Technology · US
Area of research
Infectious Diseases · Immunology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, and Immune cells in cancer.
h-index
16
citations
2,643
works
39
NIH funding
primary concept
Biology
email

Recent publications

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Nature Communications 2024cited by 11position: middledoi
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
Science 2023cited by 584position: middledoi
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
Cell Reports Medicine 2022cited by 70position: middledoi
Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children
Cell Reports Medicine 2022cited by 48position: middledoi
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
Cell Reports Medicine 2021cited by 309position: middledoi
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Cell 2021cited by 165position: middledoi
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
Journal of Clinical Investigation 2021cited by 122position: middledoi
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Science Immunology 2021cited by 87position: middledoi
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Science 2020cited by 768position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Moshe Sade-Feldman · Harvard University2 papers (2022–2024)Thomas J. LaSalle · Massachusetts Institute of Technology2 papers (2022–2024)Jacy Fang · Center for Cancer Research1 papers (2024–2024)Alessio Fasano · Harvard University1 papers (2022–2022)Sophia Z. Shalhout · Harvard University1 papers (2024–2024)Nir Hacohen · Broad Institute1 papers (2024–2024)Donald P. Lawrence · Harvard University1 papers (2024–2024)Christopher G. Azzoli · Rhode Island Hospital1 papers (2024–2024)Galit Alter · Harvard University1 papers (2022–2022)Maggie Loiselle · Massachusetts General Hospital1 papers (2022–2022)Shiv Pillai · Harvard University1 papers (2022–2022)Mari Mino–Kenudson · Harvard University1 papers (2024–2024)Judit Simon · Johannes Gutenberg University Mainz1 papers (2024–2024)Daniel Irimia · Harvard University1 papers (2022–2022)Felix Ellett · University of Sheffield1 papers (2022–2022)Meghan J. Mooradian · Harvard University1 papers (2024–2024)Soroush Hajizadeh · Krantz Family Center for Cancer Research1 papers (2022–2022)Yannic C. Bartsch · Ragon Institute of MGH, MIT and Harvard1 papers (2022–2022)David B. Sykes · University of California, Riverside1 papers (2022–2022)Aleigha Lawless · Center for Cancer Research1 papers (2024–2024)